Research area:
Having five main research interests related to Parkinsons and other movement disorders. The first is to understand and define cognitive and behavioural changes in parkinsonisms (PSP, MSA, CBS, DLB, HD) and their clinical predictors. In this regards, aiming 1) to identify the feasibility and sensitivity of cognitive tests in detecting and monitoring cognitive decline in dementia patients; 2) to implement Italian validation “PD with mild cognitive” criteria; and 3) to build up a healthy subjects database with valid information about cognitive and brain alterations progression from a healthy population-based study. This effort has been recently awarded by an NHS GR-2016-02361986 grant. The second is neuroimaging, with particular focus on the definition of specific brain neurochemical and network changes associated with neurodegeneration. MRI and fluorodeoxyglucose PET are used to understand alterations in brain networks and connectivity. The third is the neuromodulation by transcranial magnetic stimulation, to identify indicators of neurorehabilitation treatment efficacy. The fourth is development of innovative rehabilitation strategies and home monitoring. This effort has been awarded by a Horizon 2020 research grant. The fifth is focused on genetic profiles associated with cognitive and behavioural symptoms in degenerative disorders. Also aiming to improve quality of life and resilience of patients using tailored rehabilitative treatments.

Non-Research theses (literature review):
1) Depression/ideational suicide/ and cognition in PD
2) Proegressive sopranuclar pulsy (PSP): Cognitive-clinical characterization of each phenotype.
3) Mulitple system atrophy: Cognitive-clinical characterization of each parkinsonians vs. cerebellar phenotypes
4) Non pharmacological interventions in enhancing cognition in PD (NINBS, PD-based test, paper and pensil tests).
5) Dementia in Lewy Bodie diseases
6) The contribution of Beta-amyloid in PD cognitive decline
7) The neuropathology biomarker of dementia in Lewy Bodies
8) The contribution of tau pathology in PD cognitive decline
9) The neurophysiology of cognitive decline in PD.

Experimental theses:
2) New version of PD non-motor scale: an international study
3) How Motor Fluctuations affects non-motor symptoms in PD
4) Effect of Deep Brain Stimulation on Motor-non-motor symptoms in PD
5) Visuo-spatial deficits and oculomotor dysfunctions in PSP
6) The electrophiological underpinning of Impulse control disorders in PD: a EEG study
7) Huntigton disease: Clinical, cognitive and neuroimaging evidence from patients recruited at Neurology Clinic Hospital in Padua
8) Mulitple system atrophy: Clinical, cognitive and neuroimaging evidence from patients recruited at Neurology Clinic Hospital in Padua
9) PSP: Clinical, cognitive and neuroimaging evidence from patients recruited at Neurology Clinic Hospital in Padua
10) Visual hallucination in PD.
11) Rem Behavioural disorder in PD.
12) Validation of neuropsychological battery for PD:co-normed data